Table 4.
Top 5 GO terms of DEmRNAs in Uni-S vs Mul-S and Uni-L vs Mul-L
| Term | gene count | P-value | Term | gene count | P-value |
|---|---|---|---|---|---|
| Uni-S vs Mul-S | Uni-L vs Mul-L | ||||
| Biological process | |||||
| Immune system process | 45 | 3.10E-07 | Anterior/posterior pattern specification | 11 | 1.20E-07 |
| Immune response | 24 | 6.90E-05 | Definitive hemopoiesis | 4 | 9.30E-06 |
| Steroid biosynthetic process | 7 | 1.20E-04 | Regionalization | 11 | 1.10E-05 |
| Organic hydroxy Compound biosynthetic process | 8 | 2.40E-04 | Pattern specification process | 12 | 1.10E-05 |
| Superoxide anion generation | 4 | 3.00E-04 | Skeletal system morphogenesis | 9 | 1.80E-05 |
| Cellular component | |||||
| Cell surface | 18 | 4.40E-05 | Extracellular region part | 13 | 4.60E-04 |
| Extracellular region | 24 | 7.00E-05 | Extracellular region | 14 | 5.70E-04 |
| Extracellular space | 18 | 1.20E-04 | Extracellular matrix | 5 | 2.38E-03 |
| Extracellular region part | 21 | 1.70E-04 | Cell periphery | 25 | 6.60E-03 |
| Plasma membrane | 45 | 1.08E-03 | Protein C inhibitor-TMPRSS7 complex | 1 | 6.88E-03 |
| Molecular function | |||||
| Deaminase activity | 3 | 4.90E-04 | Icosanoid receptor activity | 2 | 1.20E-03 |
| Receptor activity | 17 | 6.30E-04 | Chloride channel activity | 3 | 2.70E-03 |
| Hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 3 | 6.40E-04 | Drug binding | 3 | 4.20E-03 |
| Glycogen binding | 2 | 6.50E-04 | Chloride transmembrane transporter activity | 3 | 4.20E-03 |
| Receptor binding | 24 | 6.70E-04 | Anion channel activity | 3 | 4.80E-03 |